Lepu Pharmaceutical
Integrated pharmaceutical company focused on small-molecule and peptide therapeutics. Operations include API and finished-dose manufacturing (oral solids and sterile/lyophilized injections), new-drug R&D with standardized chemistry and formulation laboratories, analytical/quality control laboratories, and nationwide commercial sales and medical affairs activities in China. The company reports GMP quality systems and participation in government-funded R&D and environmental compliance processes.
Industries
Nr. of Employees
small (1-50)
Products
Clopidogrel bisulfate tablets (75 mg, 25 mg)
Oral antiplatelet agent for prevention of atherothrombotic events in patients with recent myocardial infarction, recent ischemic stroke or established peripheral arterial disease.
Isosorbide mononitrate sustained-release tablets (40 mg)
Sustained-release nitrate formulation for chronic management and prevention of angina pectoris and adjunctive treatment in chronic congestive heart failure.
Venlafaxine hydrochloride capsules
Oral antidepressant indicated for treatment of depressive disorders and generalized anxiety disorder; includes dosing guidance and safety considerations.
Compound glycyrrhizin tablets
Oral hepatoprotective adjunct used to improve liver function in chronic liver disease.
Fluconazole tablets (50 mg, 100 mg)
Oral antifungal agent for treatment of Candida and other fungal infections, including dosing and renal adjustment information.
Sparfloxacin tablets
Oral fluoroquinolone antibiotic for treatment of respiratory, gastrointestinal, urinary and skin infections caused by susceptible organisms.
Clopidogrel bisulfate tablets (75 mg, 25 mg)
Oral antiplatelet agent for prevention of atherothrombotic events in patients with recent myocardial infarction, recent ischemic stroke or established peripheral arterial disease.
Isosorbide mononitrate sustained-release tablets (40 mg)
Sustained-release nitrate formulation for chronic management and prevention of angina pectoris and adjunctive treatment in chronic congestive heart failure.
Venlafaxine hydrochloride capsules
Oral antidepressant indicated for treatment of depressive disorders and generalized anxiety disorder; includes dosing guidance and safety considerations.
Compound glycyrrhizin tablets
Oral hepatoprotective adjunct used to improve liver function in chronic liver disease.
Fluconazole tablets (50 mg, 100 mg)
Oral antifungal agent for treatment of Candida and other fungal infections, including dosing and renal adjustment information.
Sparfloxacin tablets
Oral fluoroquinolone antibiotic for treatment of respiratory, gastrointestinal, urinary and skin infections caused by susceptible organisms.
Services
Manufacture of APIs, oral solids and sterile injectable formulations and commercialization / distribution to hospitals and retail pharmacies across China.
Manufacture of APIs, oral solids and sterile injectable formulations and commercialization / distribution to hospitals and retail pharmacies across China.
Expertise Areas
- Small-molecule drug development
- Peptide bioprocessing and injectable manufacturing
- Formulation development for oral and sterile products
- Analytical chemistry and stability testing
Key Technologies
- Lyophilization (freeze-drying)
- Fermentation and downstream processing
- High-performance liquid chromatography (HPLC)
- Atomic absorption spectroscopy (AAS)
News & Updates
Public consultation notice and link to draft environmental impact report for a new peptide-like drug production line at the company's industrial park; includes public comment procedures and contact information.
Public disclosure of hazardous waste types, codes, physical form and planned disposal method and quantities (e.g., laboratory solvents, expired reagents, waste activated carbon) and stated control and minimization measures.
First public participation notice for the environmental impact assessment of a peptide-like drug production line project, including project scope, equipment list and expected production capacity.
Announcement noting the corporate name change from the previous name to the current company name.
List of company honors including national and provincial recognitions such as high-tech enterprise status and regional quality and innovation awards.
Public consultation notice and link to draft environmental impact report for a new peptide-like drug production line at the company's industrial park; includes public comment procedures and contact information.
Public disclosure of hazardous waste types, codes, physical form and planned disposal method and quantities (e.g., laboratory solvents, expired reagents, waste activated carbon) and stated control and minimization measures.
First public participation notice for the environmental impact assessment of a peptide-like drug production line project, including project scope, equipment list and expected production capacity.
Announcement noting the corporate name change from the previous name to the current company name.
List of company honors including national and provincial recognitions such as high-tech enterprise status and regional quality and innovation awards.